Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis | Zendy

Colin A. Hutchison | Zendy; A.R. Bradwell | Zendy; Mark Cook | Zendy; Kolitha Basnayake | Zendy; Supratik Basu | Zendy; Stephen Harding | Zendy; John Hattersley | Zendy; Neil D. Evans | Zendy; Mike J Chappel | Zendy; Paul D. Sampson | Zendy; Lukas Foggensteiner | Zendy; Dwomoa Adu | Zendy; Paul Cockwell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis

Author(s) -

Colin A. Hutchison,

A.R. Bradwell,

Mark Cook,

Kolitha Basnayake,

Supratik Basu,

Stephen Harding,

John Hattersley,

Neil D. Evans,

Mike J Chappel,

Paul D. Sampson,

Lukas Foggensteiner,

Dwomoa Adu,

Paul Cockwell

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04590908

Subject(s) - medicine , digoxin , heart failure , intensive care medicine , multiple myeloma , chemotherapy , hemodialysis , cardiology

Extended hemodialysis using a high cut-off dialyzer (HCO-HD) removes large quantities of free light chains in patients with multiple myeloma. However, the clinical utility of this method is uncertain. This study assessed the combination of chemotherapy and HCO-HD on serum free light chain concentrations and renal recovery in patients with myeloma kidney (cast nephropathy) and dialysis-dependent acute renal failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research